These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 34224328)

  • 1. An emerging spectrum of variants and clinical features in
    Miller JP; Moldenhauer HJ; Keros S; Meredith AL
    Channels (Austin); 2021 Dec; 15(1):447-464. PubMed ID: 34224328
    [No Abstract]   [Full Text] [Related]  

  • 2. BK channel properties correlate with neurobehavioral severity in three
    Park SM; Roache CE; Iffland PH; Moldenhauer HJ; Matychak KK; Plante AE; Lieberman AG; Crino PB; Meredith A
    Elife; 2022 Jul; 11():. PubMed ID: 35819138
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Bailey CS; Moldenhauer HJ; Park SM; Keros S; Meredith AL
    J Gen Physiol; 2019 Oct; 151(10):1173-1189. PubMed ID: 31427379
    [No Abstract]   [Full Text] [Related]  

  • 4. BK Channelopathies and
    Meredith AL
    Annu Rev Physiol; 2024 Feb; 86():277-300. PubMed ID: 37906945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative gain-of-function effects of the
    Moldenhauer HJ; Matychak KK; Meredith AL
    J Neurophysiol; 2020 Feb; 123(2):560-570. PubMed ID: 31851553
    [No Abstract]   [Full Text] [Related]  

  • 6. Evaluation of four
    Dinsdale RL; Meredith AL
    Channels (Austin); 2024 Dec; 18(1):2396346. PubMed ID: 39217512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. De novo loss-of-function KCNMA1 variants are associated with a new multiple malformation syndrome and a broad spectrum of developmental and neurological phenotypes.
    Liang L; Li X; Moutton S; Schrier Vergano SA; Cogné B; Saint-Martin A; Hurst ACE; Hu Y; Bodamer O; Thevenon J; Hung CY; Isidor B; Gerard B; Rega A; Nambot S; Lehalle D; Duffourd Y; Thauvin-Robinet C; Faivre L; Bézieau S; Dure LS; Helbling DC; Bick D; Xu C; Chen Q; Mancini GMS; Vitobello A; Wang QK
    Hum Mol Genet; 2019 Sep; 28(17):2937-2951. PubMed ID: 31152168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural mapping of patient-associated KCNMA1 gene variants.
    Moldenhauer HJ; Tammen K; Meredith AL
    Biophys J; 2024 Jul; 123(14):1984-2000. PubMed ID: 38042986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disease-associated KCNMA1 variants decrease circadian clock robustness in channelopathy mouse models.
    Dinsdale RL; Roache CE; Meredith AL
    J Gen Physiol; 2023 Nov; 155(11):. PubMed ID: 37728576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and functional analysis of two new de novo KCNMA1 variants associated with Liang-Wang syndrome.
    Liang L; Liu H; Bartholdi D; van Haeringen A; Fernandez-Jaén A; Peeters EEA; Xiong H; Bai X; Xu C; Ke T; Wang QK
    Acta Physiol (Oxf); 2022 May; 235(1):e13800. PubMed ID: 35156297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymicrogyria in a child with KCNMA1-related channelopathy.
    Graber D; Imagawa E; Miyake N; Matsumoto N; Miyatake S; Graber M; Isidor B
    Brain Dev; 2022 Feb; 44(2):173-177. PubMed ID: 34674900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural mapping of patient-associated
    Moldenhauer HJ; Tammen K; Meredith AL
    bioRxiv; 2023 Nov; ():. PubMed ID: 37546746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lisdexamfetamine Therapy in Paroxysmal Non-kinesigenic Dyskinesia Associated with the
    Keros S; Heim J; Hakami W; Zohar-Dayan E; Ben-Zeev B; Grinspan Z; Kruer MC; Meredith AL
    Mov Disord Clin Pract; 2022 Feb; 9(2):229-235. PubMed ID: 35141357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potassium channelopathies associated with epilepsy-related syndromes and directions for therapeutic intervention.
    Gribkoff VK; Winquist RJ
    Biochem Pharmacol; 2023 Feb; 208():115413. PubMed ID: 36646291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expanding the Phenotype of Homozygous
    Yeşil G; Aralaşmak A; Akyüz E; İçağasıoğlu D; Uygur Şahin T; Bayram Y
    Balkan Med J; 2018 Jul; 35(4):336-339. PubMed ID: 29545233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional characterization of
    Yucesan E; Goncu B; Ozgul C; Kebapci A; Aslanger AD; Akyuz E; Yesil G
    Int J Neurosci; 2024 Oct; 134(10):1098-1103. PubMed ID: 37269313
    [No Abstract]   [Full Text] [Related]  

  • 17. A Gain-of-Function Mutation in KCNMA1 Causes Dystonia Spells Controlled With Stimulant Therapy.
    Zhang G; Gibson RA; McDonald M; Liang P; Kang PW; Shi J; Yang H; Cui J; Mikati MA
    Mov Disord; 2020 Oct; 35(10):1868-1873. PubMed ID: 32633875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two novel presentations of KCNMA1-related pathology--Expanding the clinical phenotype of a rare channelopathy.
    Rodrigues Bento J; Feben C; Kempers M; van Rij M; Woiski M; Devriendt K; De Catte L; Baldewijns M; Alaerts M; Meester J; Verstraeten A; Hendson W; Loeys B
    Mol Genet Genomic Med; 2021 Oct; 9(10):e1797. PubMed ID: 34499417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Large-conductance calcium-activated potassium channel haploinsufficiency leads to sensory deficits in the visual system: a case report.
    Perche O; Lesne F; Patat A; Raab S; Twyman R; Ring RH; Briault S
    J Med Case Rep; 2022 May; 16(1):180. PubMed ID: 35509069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuronal mechanism of a BK channelopathy in absence epilepsy and dyskinesia.
    Dong P; Zhang Y; Hunanyan AS; Mikati MA; Cui J; Yang H
    Proc Natl Acad Sci U S A; 2022 Mar; 119(12):e2200140119. PubMed ID: 35286197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.